Dr. Blum on Potential of CA-125 as a Biomarker for Renal Medullary Carcinoma
February 13th 2023Kyle A. Blum, MD, MS, says that results from a study of patients renal medullary carcinoma suggest that with CA-125, an established biomarker for ovarian cancer, may play a similar role in this rare disease.
Read More